Literature DB >> 7490457

Characterization of mouse nasal lymphocytes isolated by enzymatic extraction with collagenase.

H Asanuma1, Y Inaba, C Aizawa, T Kurata, S Tamura.   

Abstract

A reproducible method for isolation of mouse nasal lymphocytes was developed. The cells were released from tissue fragments of dissected mouse nose by enzyme extraction with collagenase and separated by a stepwise Percoll gradient centrifugation. The partially purified nasal lymphocyte fraction from normal BALB/c mice contained CD4+ T cells (18-23%), CD8+ T cells (7-10%) and B cells (20-38%), when analysed with a FACScan fluorescence analyser. The ratio of T to B cells and that of CD4+ to CD8+ T cells in the nasal cell fraction were about twice as high as those in Peyer's path lymphocytes. The nasal lymphocyte fraction from the mice infected with influenza virus was then characterized. The nasal lymphocytes contained a twice larger number of CD4+ and a three times larger number of CD8+ T cells than those of normal mice 7 days after infection. They produced IFN-gamma which increased after infection. They contained the cells secreting influenza virus-specific IgA and IgG antibodies 4 weeks after infection. Moreover, the nasal lymphocytes from infected C3H mice lysed the virus infected-target cells. These results suggest that this method can successfully be used for investigating cellular dynamics of mucosal immunity in the upper respiratory tract of experimental animals.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7490457     DOI: 10.1016/0022-1759(95)00165-7

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  13 in total

1.  Nasal-associated lymphoid tissue is a site of long-term virus-specific antibody production following respiratory virus infection of mice.

Authors:  B Liang; L Hyland; S Hou
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

2.  Route of nutrition influences generation of antibody-forming cells and initial defense to an active viral infection in the upper respiratory tract.

Authors:  Cheryl D Johnson; Kenneth A Kudsk; Kazuhiko Fukatsu; Kathryn B Renegar; Ben L Zarzaur
Journal:  Ann Surg       Date:  2003-04       Impact factor: 12.969

3.  Characterization and TCR variable region gene use of mouse resident nasal gammadelta T lymphocytes.

Authors:  Chang-Hoon Kim; Deborah A Witherden; Wendy L Havran
Journal:  J Leukoc Biol       Date:  2008-07-30       Impact factor: 4.962

4.  Parenteral nutrition induces organ specific alterations in polymeric immunoglobulin receptor levels.

Authors:  Yoshifumi Sano; F Enrique Gomez; Joshua L Hermsen; Woodae Kang; Jinggang Lan; Yoshinori Maeshima; Kenneth A Kudsk
Journal:  J Surg Res       Date:  2008-01-29       Impact factor: 2.192

5.  Listeriolysin O derived from Listeria monocytogenes inhibits the effector phase of an experimental allergic rhinitis induced by ovalbumin in mice.

Authors:  K Yamamoto; I Kawamura; T Tominaga; T Nomura; J Ito; M Mitsuyama
Journal:  Clin Exp Immunol       Date:  2006-06       Impact factor: 4.330

6.  A novel combined adjuvant for nasal delivery elicits mucosal immunity to influenza in aging.

Authors:  Hideki Asanuma; Normaiza Binti Zamri; Shinichi Sekine; Yoshiko Fukuyama; Daisuke Tokuhara; Rebekah S Gilbert; Tatsuya Fukuiwa; Keiko Fujihashi; Tetsutaro Sata; Masato Tashiro; Kohtaro Fujihashi
Journal:  Vaccine       Date:  2011-11-17       Impact factor: 3.641

7.  A second generation of double mutant cholera toxin adjuvants: enhanced immunity without intracellular trafficking.

Authors:  Yukari Hagiwara; Yuki I Kawamura; Kosuke Kataoka; Bibi Rahima; Raymond J Jackson; Katsuhiro Komase; Taeko Dohi; Prosper N Boyaka; Yoshifumi Takeda; Hiroshi Kiyono; Jerry R McGhee; Kohtaro Fujihashi
Journal:  J Immunol       Date:  2006-09-01       Impact factor: 5.422

8.  Local and systemic antibody responses in mice immunized intranasally with native and detergent-extracted outer membrane vesicles from Neisseria meningitidis.

Authors:  Terry Guthrie; Simon Y C Wong; Bin Liang; Lisa Hyland; Sam Hou; E Arne Høiby; Svein Rune Andersen
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

9.  A combination of Flt3 ligand cDNA and CpG ODN as nasal adjuvant elicits NALT dendritic cells for prolonged mucosal immunity.

Authors:  Tatsuya Fukuiwa; Shinichi Sekine; Ryoki Kobayashi; Hideaki Suzuki; Kosuke Kataoka; Rebekah S Gilbert; Yuichi Kurono; Prosper N Boyaka; Arthur M Krieg; Jerry R McGhee; Kohtaro Fujihashi
Journal:  Vaccine       Date:  2008-07-14       Impact factor: 3.641

10.  Intranasal immunization with polymer-grafted microparticles activates the nasal-associated lymphoid tissue and draining lymph nodes.

Authors:  P L Heritage; M A Brook; B J Underdown; M R McDermott
Journal:  Immunology       Date:  1998-02       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.